Trial reportJAMA neurology2018
Timolol Eyedrops in the Treatment of Acute Migraine Attacks: A Randomized Crossover Study.
Trial report in JAMA neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Migraine relief in 20 minutes using eyedrops?The Journal of family practice · 2022Trial
- Answering the Call: A Prospective Look at the Role of Timolol Eye Drops in the Treatment of Acute Migraine Attacks.Missouri medicineTrial
- Approach to Pediatric Intractable Migraine.Current neurology and neuroscience reports · 2021Review
- A Case of Recurrent Painful Ophthalmoplegic Neuropathy Successfully Treated with Beta-blocker Eye Drop Instillation.Neuro-ophthalmology (Aeolus Press) · 2021Article
- Breakthroughs on the clinical management of headache and questions that need to be solved.Ibrain · 2021Review
- A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.Kansas journal of medicine · 2020Article
- Error in Data Presentation in Text.JAMA neurology · 2018Article
- Errors in the Table and Results.JAMA neurology · 2018Article
- Article
- Topical Beta Blockers for the Treatment of Acute Migraines in 2019.Missouri medicineArticle
- Nasally Delivered 0.5% Timolol Beta Blocker Successfully Treats Acute Migraines in a Referral Headache Clinic: A Case Series.Missouri medicineArticle
- First World Literature Report: Attention Pharma & Headache Researchers! Nasal Spray Timolol May Be the Next Great Thing for Acute Migraine.Missouri medicineArticle
- Mixing It Up: The Art and Science of Compounding Pharmacy.Missouri medicineArticle
Corrections and comments
- Erratum issued
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.